Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/53715
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWodak, A.en
dc.contributor.authorAli, R.en
dc.contributor.authorSansom, L.en
dc.contributor.authorHenry, D.en
dc.date.issued2008en
dc.identifier.citationMedical Journal of Australia, 2008; 188(8):438-439en
dc.identifier.issn0025-729Xen
dc.identifier.issn1326-5377en
dc.identifier.urihttp://hdl.handle.net/2440/53715-
dc.description.statementofresponsibilityAlex D. Wodak, Robert Ali, David Henry and Lloyd Sansomen
dc.language.isoenen
dc.publisherAustralasian Med Publ Co Ltden
dc.source.urihttp://www.mja.com.au/public/issues/188_08_210408/wod10120_fm.htmlen
dc.subjectHumans; Opioid-Related Disorders; Naltrexone; Narcotic Antagonists; Capsules; Drug Implants; Drug Monitoring; Patient Satisfaction; Australiaen
dc.titleEnsuring the safety of new medications and devices: are naltrexone implants safe?en
dc.typeJournal articleen
dc.identifier.rmid0020080759en
dc.identifier.doi10.5694/j.1326-5377.2008.tb01711.xen
dc.identifier.pubid43325-
pubs.library.collectionMedical Sciences publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidAli, R. [0000-0003-2905-8153]en
Appears in Collections:Medical Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.